Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GBP3 mRNA | CTD | PMID:22079256 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GBP3 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GBP3 mRNA | CTD | PMID:33387578 | 2-palmitoylglycerol | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of GBP3 mRNA | CTD | PMID:37199045 | aflatoxin B1 | decreases methylation | ISO | GBP3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GBP3 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GBP3 mRNA | CTD | PMID:23830798 and PMID:33167477 | antirheumatic drug | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GBP3 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | GBP3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of GBP3 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | GBP3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of GBP3 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GBP3 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases methylation | ISO | GBP3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GBP3 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GBP3 mRNA | CTD | PMID:25181051 | bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of GBP3 mRNA | CTD | PMID:32479839 | Calcimycin | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA and fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA] | CTD | PMID:21331654 | calcitriol | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of GBP3 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GBP3 mRNA | CTD | PMID:21592394 | CGP 52608 | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GBP3 gene] | CTD | PMID:28238834 | cyclosporin A | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GBP3 mRNA | CTD | PMID:27989131 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of GBP3 mRNA | CTD | PMID:33729688 | doxorubicin | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GBP3 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of GBP3 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | entinostat results in increased expression of GBP3 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GBP3 mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GBP3 mRNA | CTD | PMID:23649840 | Fulvic acid | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA] | CTD | PMID:21331654 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GBP3 mRNA | CTD | PMID:33387578 | malathion | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Malathion results in increased expression of GBP3 mRNA | CTD | PMID:37047231 | methyl methanesulfonate | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GBP3 mRNA | CTD | PMID:23649840 | nickel atom | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of GBP3 mRNA | CTD | PMID:23195993 | nickel atom | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Nickel results in increased expression of GBP3 mRNA | CTD | PMID:25583101 | paracetamol | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GBP3 mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GBP3 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GBP3 mRNA | CTD | PMID:26690555 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of GBP3 mRNA | CTD | PMID:27153767 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA and fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA] | CTD | PMID:21331654 | potassium chromate | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GBP3 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of GBP3 mRNA | CTD | PMID:22079256 | silicon dioxide | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GBP3 mRNA | CTD | PMID:25895662 | testosterone | multiple interactions | ISO | GBP3 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GBP3 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Testosterone results in increased expression of GBP3 mRNA | CTD | PMID:21592394 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GBP3 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of GBP3 mRNA | CTD | PMID:33387578 | valproic acid | decreases expression | ISO | GBP3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GBP3 mRNA | CTD | PMID:29154799 | |